Vericel Corporation (VCEL) vs Vera Therapeutics, Inc. (VERA)

A side-by-side comparison of Vericel Corporation and Vera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Vericel Corporation logo
VCEL
Vericel Corporation
$2.06B
$40.18HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Vera Therapeutics, Inc. logo
VERA
Vera Therapeutics, Inc.
$2.08B
$29.00HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT

Total return — VCEL vs VERA

growth of $100 · dividends reinvested · last 5y
VCEL -22.0% (-4.8%/yr)VERA +159.4% (+21.0%/yr)VERA compounded faster over this window
100200300400500Start $10020222023202420252026$78$259
VCEL VERA

VCEL vs VERA: by the numbers

  • •VERA is the larger company ($2.08B vs $2.06B market cap).
  • •VCEL is profitable (7.91% net margin) while VERA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricVCELVERA
P/E ratio85.89N/A
Forward P/E75.18N/A
PEG ratio2.18N/A
P/S ratio6.72N/A
P/B ratio5.565.11
EV / EBITDA65.36N/A
FCF yield2.41%N/A

Profitability

MetricVCELVERA
Gross margin74.56%0.00%
Operating margin5.95%0.00%
Net margin7.91%0.00%
ROE6.55%-98.56%
ROIC3.79%-85.78%

Growth (annualized)

MetricVCELVERA
Revenue CAGR (5Y)15.11%N/A
EPS CAGR (5Y)39.14%N/A
FCF CAGR (5Y)14.83%N/A
Total return CAGR (5Y)-4.18%14.09%

Frequently asked

Is VCEL or VERA more profitable?
VCEL runs the higher net margin — VCEL at 7.91% versus VERA at 0.00%.
How have VCEL and VERA total returns compared?
Over the past 5 years, VCEL delivered -4.18% and VERA delivered 14.09% annualized total return. Past performance doesn't predict future results.

Go deeper

Full VCEL analysisFull VERA analysisInteractive comparison tool

Dig into the metrics

Vericel P/E ratioVericel ROEVera Therapeutics ROEVericel operating marginVera Therapeutics operating marginVericel revenue growthVera Therapeutics revenue growthVericel free cash flowVera Therapeutics free cash flow

Vericel & Vera Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.